Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 756 | 15,663 | 3,926 | 3,414 | 11,483 |
| Cost of Goods | 3,337 | 2,794 | 2,197 | 1,961 | 3,571 |
| Gross Profit | -2,580 | 12,869 | 1,729 | 1,453 | 7,912 |
| Operating Expenses | 20,595 | 18,116 | 20,624 | 16,947 | 22,363 |
| Operating Income | -23,175 | -5,247 | -18,895 | -15,494 | -14,451 |
| Interest Expense | 231 | 16 | -75 | 10 | 1,126 |
| Other Income | 1,347 | 1,015 | -2,147 | 2,496 | 429 |
| Pre-tax Income | -22,059 | -4,248 | -20,967 | -13,007 | -15,148 |
| Income Tax | -2,377 | -1,880 | -1,055 | -2,942 | -2,029 |
| Net Income Continuous | -19,683 | -2,368 | -19,912 | -10,066 | -13,119 |
| Net Income | $-19,683 | $-2,368 | $-19,912 | $-10,066 | $-13,119 |
| EBITDA(a) | $-21,677 | $-4,080 | $-20,868 | $-12,856 | $-13,870 |